St. Jude: Device tax not solely to blame for layoffs

St. Jude Medical's ($STJ) recently announced job cuts and business realignment are designed to save between $50 million and $60 million a year, the same amount the company expects to lose to the incoming medical device tax. But that's just "a coincidence," Executive Vice President John Heinmiller told MassDevice. The cuts were a response to "a lot of different cost pressures" the company is facing, he said. Report

Suggested Articles

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.